Clinical Trials · NCT03479762
In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 105
- Start date
- Apr 2018
- Locations
- 1 site, Denmark
- Primary endpoint
- Number of patients with a BMI above or equal to 30 kg/m^2 (Saxenda® only)